MMS Holdings, a Mississippi-based global CRO that focuses on regulatory submission support, and Oncology Trials Insights (OTI), a Colorado-based organization of oncology key opinion leaders that architect superior clinical trial strategies and facilitate improved decision-making, have partnered to deliver comprehensive oncology support services.

“The partnership between MMS and OTI centers on our collective desire to improve the speed and efficiency of oncology drug development,” said Joseph Giglio, president and CEO of OTI.

The strategic partnership will leverage MMS Holdings’ robust regulatory, clinical data management, medical writing and biostatistics experience with OTI’s protocol development, study site selection and enrollment management services. It will offer unique oncology services organizations can leverage to enhance their drug development pipeline and all of the aspects of their clinical trials.